alpha-cyano-4-hydroxycinnamate has been researched along with Heart Failure in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, RK | 1 |
| Schwartz, DD | 1 |
| Gladden, LB | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Heart Failure
| Article | Year |
|---|---|
Effect of myocardial volume overload and heart failure on lactate transport into isolated cardiac myocytes.
Topics: Animals; Biological Transport, Active; Blotting, Western; Body Weight; Buffers; Butyrates; Cell Sepa | 2003 |